Scholars@Duke
Jeffrey Harold Lawson

Jeffrey Harold Lawson

Adjunct Professor in the Department of Surgery
Surgery, Vascular and Endovascular Surgery
jeffrey.lawson@duke.edu
Box 2622 Med Ctr, Durham, NC
481 Med Sci Res Bldg, Durham, NC

Overview

The research interests of my laboratory include the study of vascular biology and cellular differentiation of vascular tissue, the proteolytic and cell mediated regulation of blood coagulation, inflammatory mediated thrombosis, and the development of bioengineered blood vessels. The clinical interests of my laboratory include the study of novel therapies for vascular and cardiovascular surgery, thrombosis related to surgical procedures, clinical inhibitors of blood coagulation proteases, and the study of the immune response to biologics used in surgery.

Current Appointments & Affiliations

Adjunct Professor in the Department of Surgery · 2018 - Present Surgery, Vascular and Endovascular Surgery, Surgery
Core Faculty in Innovation & Entrepreneurship · 2018 - Present Duke Innovation & Entrepreneurship, University Initiatives & Academic Support Units

In the News

Published March 15, 2017
Growing Medical Device Company InnAVasc Could Reduce Dialysis Complications
Published May 17, 2016
Lab-grown blood vessels appear a safe alternative to synthetic implants
Published May 12, 2016
Bioengineered Blood Vessel Appears Safe for Dialysis Patients

View All News

Recent Publications

Evaluation of tissue-engineered human acellular vessels as a Blalock-Taussig-Thomas shunt in a juvenile primate model.

Journal Article JTCVS Open · September 2023 OBJECTIVES: Palliative treatment of cyanotic congenital heart disease (CCHD) uses systemic-to-pulmonary conduits, often a modified Blalock-Taussig-Thomas shunt (mBTTs). Expanded polytetrafluoroethylene (ePTFE) mBTTs have associated risks for thrombosis and ... Full text Link to item Cite

Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass.

Journal Article JVS Vasc Sci · 2023 OBJECTIVE: The human acellular vessel (HAV) was evaluated for surgical bypass in a phase II study. The primary results at 24 months after implantation have been reported, and the patients will be evaluated for ≤10 years. METHODS: In the present report, we ... Full text Link to item Cite

Patient-reported outcomes in hemodialysis vascular access: A call to action.

Journal Article J Vasc Access · November 2022 While access-related dysfunction is a clear driver of clinical outcomes and costs, the full impact of vascular access dysfunction on patient experience and quality of life is not fully characterized in the literature. One way to more comprehensively charac ... Full text Link to item Cite
View All Publications

Recent Grants

Skeletal Muscle and Vascular Remodeling in Peripheral Artery Disease

ResearchCollaborator · Awarded by National Institutes of Health · 2015 - 2018

Exercise, Nitric Oxide Bioavailability and Arteriovenous Fistula Maturation

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2017

HeRO Graft Registry Protocol

Clinical TrialPrincipal Investigator · Awarded by CryoLife · 2014 - 2017

View All Grants

Education, Training & Certifications

University of Vermont · 1992 Ph.D.
University of Vermont · 1991 M.D.